Trials / Sponsors / Palladio Biosciences
Palladio Biosciences
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Roll-over Study to Assess Safety of Lixivaptan in Participants With ADPKD Who Completed Study PA-ADPKD-303 Polycystic Kidney Disease, Adult | Phase 3 | 2022-02-10 |
| Terminated | Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease Autosomal Dominant Polycystic Kidney, ADPKD | Phase 3 | 2021-10-28 |
| Terminated | Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Di Polycystic Kidney Disease, Adult, ADPKD | Phase 3 | 2020-09-02 |
| Completed | The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease Autosomal Dominant Polycystic Kidney Disease | Phase 2 | 2018-09-14 |
| No Longer Available | Lixivaptan in a Single Subject With Intractable Pain Due to Polycystic Kidney Disease Polycystic Kidney | — | — |